Breast Cancer Therapeutics in Southeast Asia Markets to 2022 - Increasing Prevalence and Usage of Premium Targeted Therapies to Drive the Market

Market: Pharmaceuticals and Healthcare

Asia Pacific, 176 pages report, published by GBI Research

Report ThumbnailApril-2017
Breast Cancer Therapeutics in Southeast Asia Markets to 2022 - Increasing Prevalence and Usage of Premium Targeted Therapies to Drive the Market

Summary

Breast cancer is a malignant neoplasm that begins in the breast tissue. Most breast cancers are invasive cancers that have grown beyond the ducts or lobules and can metastasize to other parts of the body through the bloodstream and the lymphatic system. Broadly, patients can be segmented into two types: the human epidermal growth factor recept

Read More
  • 1.2 List of Figures
  • Figure 1: Breast Cancer Therapeutics, Southeast Asia, Age-Standardized Incidence (per 100,000 population), 2012 12
  • Figure 2: Breast Cancer Therapeutics, South Korea, Age-Specific Incidence (%), 2012 13
  • Figure 3: Breast Cancer Therapeutics, Southeast Asia, Age-Standardized Mortality (per 100,000 population), 2012 14
  • Figure 4: Breast Cancer Therapeutics, Global, Treatment Algorithm for Cancer Diagnosed at Stages I-III 24
  • Figure 5: Breast Cancer Therapeutics, Global, Treatment A
Read More
  • 1.1 List of Tables
  • Table 1: Breast Cancer Therapeutics, Global, Tumor, Nodes and Metastasis Staging, 2010-2013 18
  • Table 2: Breast Cancer Therapeutics, Southeast Asia, Five-year Survival Rate (%) 19
  • Table 3: Breast Cancer Therapeutics Market, Global, Licensing Deals in Southeast Asia and Deals with Disclosed Values, 2006-2016 110
  • Table 4: Breast Cancer Therapeutics Market, Global, Co-development Deals in Southeast Asia and Deals with Disclosed Values, 2006-2016 117
  • Table 5: Breast Cancer Therapeu
Read More
  • 1 Table of Contents
  • 1 Table of Contents 5
  • 1.1 List of Tables 8
  • 1.2 List of Figures 8
  • 2 Introduction 11
  • 2.1 Disease Introduction 11
  • 2.2 Epidemiology 12
  • 2.3 Symptoms 14
  • 2.4 Etiology 15
  • 2.5 Pathophysiology 16
  • 2.6 Diagnosis 16
  • 2.7 Prognosis and Disease Staging 18
  • 2.8 Treatment Options 20
  • 2.8.1 Surgery and Radiation Therapy 20
  • 2.8.2 Chemotherapy 21
  • 2.8.3 Hormonal Therapies 21
  • 2.8.4 Targeted Therapies 22
  • 2.9 Treatment Guidelines 23
  • 3 Marketed Products 26
  • 3.1 Overview 26
  • 3.1.1 Herceptin (trastuzumab) -
Read More

Please select a license type

Share

Related Products

GBI ResearchBreast Cancer Therapeutics in Southeast Asia Markets to 2022 - Increasing Prevalence and Usage of Premium Targeted Therapies to Drive the MarketProduct ThumbnailBreast Cancer Therapeutics in Southeast Asia Markets to 2022 - Increasing Prevalence and Usage of Premium Targeted Therapies to Drive the Market, Industry ReportProduct #: 769941
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2021 Global Market Analyst. All Rights Reserved